Bone mass regulation of leptin and postmenopausal osteoporosis with obesity

Clinical Cases in Mineral and Bone Metabolism

Volumn 9, Issue 3, 2012, Pages 145-149

  Legiran, Siswo ^a   Brandi, Maria Luisa ^b  

^a SRIWIJAYA UNIVERSITY   (Indonesia)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Estrogen; Leptin; Leptin receptor; OPG; RANKL

Indexed keywords

ESTROGEN; LEPTIN; OSTEOCLAST DIFFERENTIATION FACTOR;

ARTICLE; BONE DENSITY; BONE MASS; ESTROGEN DEFICIENCY; HUMAN; MOLECULAR GENETICS; OBESITY; OSTEOCLAST; OSTEOCLASTOGENESIS; POSTMENOPAUSE OSTEOPOROSIS;

EID: 84871872046     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269(5223):543-6.
2. Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 2009;43(4):157-68.
3. Farooqi IS, O'Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009;89(3): 980S-984S.
4. Reid IR. Adipokine Effects on Bone. Clinic Rev Bone Miner Metab 2009;7: 240-248.
5. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006;393(Pt 1): 7-20. (Pubitemid 43049298)
6. Huang L, Li C. Leptin: a multifunctional hormone. Cell Res 2000;10(2): 81-92.
7. Zhang F, Chen Y, Heiman M, Dimarchi R. Leptin: structure, function and biology. Vitam Horm 2005;71: 345-72. (Pubitemid 43589034)
8. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372(6505):425-32. (Pubitemid 24365442)
9. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature Edizioni 1998;395(6704):763-70. (Pubitemid 28485436)
10. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al. Identification and expression cloning of a leptin receptor, OBR. Cell 1995;83(7):1263-71. (Pubitemid 26007816)
11. Hoggard N, Mercer JG, Rayner DV, Moar K, Trayhurn P, Williams LM. Localization of leptin receptor mRNA splice variants in murine CIC peripheral tissues by RT-PCR and in situ hybridization. Biochem Biophys Res Commun 1997;232(2):383-7. (Pubitemid 27216224)
12. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379(6566):632-5. (Pubitemid 26053452)
13. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010;152(2):93-100.
14. Paracchini V, Pedotti P, Taioli E. Genetics of leptin and obesity: a HuGE review. Am J Epidemiol 2005;162(2):101-14. (Pubitemid 41373535)
15. Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004;59:305-31.
16. Thompson DB, Ravussin E, Bennett PH, Bogardus C. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet 1997;6(5):675-9. (Pubitemid 27199060)
17. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100(2):197-207. (Pubitemid 30064908)
18. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, et al. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 2002;109(7):915-21. (Pubitemid 34275112)
19. Hamrick MW, Ferrari SL. Leptin and the sympathetic connection of fat to bone. Osteoporos Int 2008;19(7):905-12. (Pubitemid 351758616)
20. Cirmanova V, Bayer M, Starka L, Zajickova K. The effect of leptin on bone: an evolving concept of action. Physiol Res 2008;57 Suppl 1:S143-51.
21. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 2000;92(1-3):73-8.
22. Lee YJ, Park JH, Ju SK, You KH, Ko JS, Kim HM. Leptin receptor isoform expression in rat osteoblasts and their functional analysis. FEBS Lett 2002;528(1-3):43-7. (Pubitemid 35257997)
23. Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 2002;175(2):405-15. (Pubitemid 35414387)
24. Scheller EL, Song J, Dishowitz MI, Soki FN, Hankenson KD, Krebsbach PH. Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells 2010;28(6):1071-80.
25. Iwamoto I, Fujino T, Douchi T. The leptin receptor in human osteoblasts and the direct effect of leptin on bone metabolism. Gynecol Endocrinol 2004;19(2):97-104. (Pubitemid 39331410)
26. Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M, et al. Leptin inhibits osteoclast generation. J Bone Miner Res 2002;17(2):200-9. (Pubitemid 34087652)
27. Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 2002;22(4):549-53. (Pubitemid 34408732)
28. Bluher S, Mantzoros CS. Leptin in humans: lessons from translational research. Am J Clin Nutr 2009;89(3):991S-997S.
29. Friedman JM. The function of leptin in nutrition, weight, and physiology. Nutr Rev 2002;60(10 Pt 2):S1-14; discussion S68-84, 85- 7.
30. Gnacinska M, Malgorzewicz S, Guzek M, Lysiak-Szydlowska W, Sworczak K. Adipose tissue activity in relation to overweight or obesity. Endokrynol Pol 2010;61(2):160-8.
31. Reid IR. Relationships between fat and bone. Osteoporosis International: A Journal Established As Result Of Cooperation Between The European Foundation For Osteoporosis And The National Osteoporosis Foundation Of The USA 2008;19(5):595-606.
32. Liu SQ, Wu J, Mo J, Sun ZX, Yang HB, Huang CW, et al. Serum leptin level and its association with bone mineral density in obese children. Zhongguo Dang Dai Er Ke Za Zhi 2009;11(9):745-8.
33. Reid IR. Obesity and osteoporosis. Ann Endocrinol (Paris) 2006;67(2):125-9.
34. Silva HG, Mendonca LM, Conceicao FL, Zahar SE, Farias ML. Influence of obesity on bone density in postmenopausal women. Arq Bras Endocrinol Metabol 2007;51(6):943-9.
35. Albala C, Yanez M, Devoto E, Sostin C, Zeballos L, Santos JL. Obesity as a protective factor for postmenopausal osteoporosis. Int J Obes Relat Metab Disord 1996;20(11):1027-32. (Pubitemid 26366457)
36. Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, et al. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 2008;23(1):17-29.
37. Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 2007;92(5):1640-6. (Pubitemid 46997165)
38. Kim KC, Shin DH, Lee SY, Im JA, Lee DC. Relation between Obesity and Bone Mineral Density and Vertebral Fractures in Korean Postmenopausal Women. Yonsei Med J 2010;51(6):857-63.
39. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2006;2(1):35-43. (Pubitemid 43153647)
40. Wardlaw GM. Putting body weight and osteoporosis into perspective. Am J Clin Nutr 1996;63(3 Suppl):433S-436S. (Pubitemid 26075826)
41. Brandi ML. Microarchitecture, the key to bone quality. Rheumatology (Oxford) 2009;48 Suppl 4:iv3-8.
42. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005;115(12):3318-25. (Pubitemid 43121814)
43. Lerner UH. Bone remodeling in post-menopausal osteoporosis. J Dent Res 2006;85(7):584-95. (Pubitemid 44085947)
44. Shapses SA, Riedt CS. Bone, body weight, and weight reduction: what are the concerns? J Nutr 2006;136(6):1453-6. (Pubitemid 43765343)
45. Seeman E. Invited Review: Pathogenesis of osteoporosis. J Appl Physiol 2003;95(5):2142-51. (Pubitemid 37310402)
46. Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/ RANKL/RANK system for bone and vascular diseases. JAMA 2004;292(4):490-5. (Pubitemid 38988958)
47. Shevde NK, Bendixen AC, Dienger KM, Pike JW. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci U S A 2000;97(14):7829-34. (Pubitemid 30460733)
48. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 2003;111(8):1221-30. (Pubitemid 36519939)
49. Petzel M. Action of leptin on bone and its relationship to menopause. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151(2):195-9.
50. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. Journal Of Molecular Medicine (Berlin, Germany) 2001;79(5-6):243-253. (Pubitemid 32646379)
51. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89(2):309-19. (Pubitemid 27199902)
52. Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 2007;9 Suppl 1:S1.
53. Lin JM, Callon KE, Lin CQ, Bava U, Zheng MH, Reid IR, et al. Alteration of bone cell function by RANKL and OPG in different in vitro models. Eur J Clin Invest 2007;37(5):407-15. (Pubitemid 46653142)
54. Tanaka H, Mine T, Ogasa H, Taguchi T, Liang CT. Expression of RANKL/OPG during bone remodeling in vivo. Biochem Biophys Res Commun 2011;411(4):690-4.